Eli Lilly and Company (NYSE:LLY) develops and markets pharmaceuticals for diabetes, oncology, immunology, neuroscience, and other therapeutic areas worldwide.
Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...
Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...
Barchart on MSN16h
Bank of America: 3 Stocks to Buy for Future Stock Split PotentialAccording to Bank of America, several companies are prime candidates for a stock split in the near future, which could lead ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings ...
Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of companies have accomplished this feat in the recent past, and I’m going to discuss ...
Zacks.com on MSN4d
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings UpdateThis week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback